Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?
Authors:
- Paolo VerdecchiaPVPaolo Verdecchia
- Fabio AngeliFabio Angeli
- Paola AchilliPAPaola Achilli
- Claudia CastellaniCCClaudia Castellani
- Andrea BroccatelliABAndrea Broccatelli
- Roberto GattobigioRGRoberto Gattobigio
- Claudio CavalliniCCClaudio Cavallini
- 1 July 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 22 (4) , 329-334
Abstract
To discuss the most relevant studies on the prognostic impact of echocardiographic left ventricular hypertrophy in hypertension. There is abundant evidence from epidemiological studies that increased left ventricular mass identifies hypertensive patients at increased risk of major cardiac and cerebrovascular events. Looking at the geometric patterns of the left ventricle, concentric remodelling and concentric left ventricular hypertrophy carry the highest risk for adverse events. Patients with left ventricular hypertrophy reversal as an effect of treatment are exposed to a lesser risk of events as compared with patients with persistence of left ventricular hypertrophy. Reversal of concentric remodelling predicts a lesser risk of adverse events compared with persistence of remodelling. Experimental evidence is accumulating that several haemodynamic and nonhaemodynamic factors which are able to promote progression of atherosclerosis through plaque growth and destabilization may also induce left ventricular hypertrophy by acting on myocyte and interstitium. Increased left ventricular mass may also be a causative factor for reduced pumping performance and arrhythmias. Increased left ventricular mass is a marker of cardiovascular risk because it reflects and integrates the long-term level of activity of factors inducing progression of atherosclerosis. Increased left ventricular mass may also mediate myocardial ischaemia with potential evolution towards heart failure and arrhythmias.Keywords
This publication has 39 references indexed in Scilit:
- Left Ventricular Hypertrophy in Severe ObesityHypertension, 2007
- Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidneyProceedings of the National Academy of Sciences, 2006
- Left Ventricular Geometry and Mortality in Patients >70 Years of Age With Normal Ejection FractionThe American Journal of Cardiology, 2006
- Increased Ambulatory Arterial Stiffness Index Is Associated With Target Organ Damage in Primary HypertensionHypertension, 2006
- Evidence of a Dominant Backward-Propagating “Suction” Wave Responsible for Diastolic Coronary Filling in Humans, Attenuated in Left Ventricular HypertrophyCirculation, 2006
- Left Ventricular Geometry and Survival in Patients With Normal Left Ventricular Ejection FractionThe American Journal of Cardiology, 2006
- Prognostic Value of Left Ventricular Mass and Geometry in Systemic Hypertension with Left Ventricular HypertrophyThe American Journal of Cardiology, 1996
- Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophyThe American Journal of Cardiology, 1996
- Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitroCell, 1993
- Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular HypertrophyNew England Journal of Medicine, 1987